Fullerton Fund Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Sell
1,137
-52
-4% -$52.7K 0.08% 39
2025
Q4
$1.28M Sell
1,189
-115
-9% -$110K 0.06% 36
2025
Q3
$995K Sell
1,304
-8,965
-87% -$6.67M 0.04% 43
2025
Q2
$8M Buy
10,269
+430
+4% +$334K 0.32% 38
2025
Q1
$8.13M Sell
9,839
-21,363
-68% -$17.8M 0.52% 37
2024
Q4
$24.1M Sell
31,202
-4,828
-13% -$4M 0.84% 29
2024
Q3
$31.9M Sell
36,030
-17,471
-33% -$15.7M 1.34% 28
2024
Q2
$48.4M Sell
53,501
-685
-1% -$548K 2.17% 14
2024
Q1
$42.2M Buy
54,186
+3,514
+7% +$2.5M 2% 13
2023
Q4
$29.5M Sell
50,672
-17,701
-26% -$10.3M 1.72% 17
2023
Q3
$36.7M Buy
68,373
+11,261
+20% +$5.8M 2.57% 14
2023
Q2
$26.8M Sell
57,112
-11,815
-17% -$4.95M 1.87% 17
2023
Q1
$23.7M Sell
68,927
-39,688
-37% -$13.4M 1.8% 22
2022
Q4
$39.7M Sell
108,615
-22,664
-17% -$8.04M 2.96% 14
2022
Q3
$42.4M Buy
+131,279
New +$41.6M 3.16% 14

Other funds holding LLY

Fullerton Fund Management's LLY Position: Q1 2026 in Review

Fullerton Fund Management reduced its Eli Lilly (LLY) stake by 4.4% in Q1 2026, selling an estimated $52.7K and leaving 1,137 shares worth $1.05M. The position accounts for 0.08% of the portfolio, ranked #39.

Fullerton Fund Management first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $48.4M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fullerton Fund Management held 1,137 shares of Eli Lilly worth $1.05M as of Q1 2026.
  • Fullerton Fund Management sold 52 Eli Lilly shares in Q1 2026, an estimated $52.7K.
  • Eli Lilly made up 0.08% of Fullerton Fund Management's portfolio in Q1 2026, its #39 holding.
  • Fullerton Fund Management first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Fullerton Fund Management's Eli Lilly position peaked at $48.4M in Q2 2024.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fullerton Fund Management's 13F filing for Q1 2026, filed 15 May 2026.